Perform Another (Advanced) Search

1.  Study Posting (799) Trial #163070, Sleep Disorders, Boston, MA
...Study Posting (799) Trial #163070, Sleep Disorders, Boston, MA Trial Information The Role of Lung Volume in Asthma Volunteers with Asthma Wanted For a Research Study of Lung Volumes During Sleep Men and women with asthma, aged 18 to 65, are needed to ...
View Page

2.  Study Posting (5258) Trial #145394, Non-Small Cell Lung Cancer, Bangkok, Thailand
...Study Posting (5258) Trial #145394, Non-Small Cell Lung Cancer, Bangkok, Thailand Trial Information MAGRIT is a Phase III clinical study which evaluates the ...
...potential new immunotherapy (also called a therapeutic vaccine) in the treatment of Non-Small Cell Lung Cancer (NSCLC). Objective: Because of the needs for alternative lung cancer treatments , this Phase III ...
View Page

3.  Study Posting (5258) Trial #145393, Non-Small Cell Lung Cancer, Taipei, Taiwan
...Study Posting (5258) Trial #145393, Non-Small Cell Lung Cancer, Taipei, Taiwan Trial Information MAGRIT is a Phase III clinical study which evaluates the ...
...potential new immunotherapy (also called a therapeutic vaccine) in the treatment of Non-Small Cell Lung Cancer (NSCLC). Objective: Because of the needs for alternative lung cancer treatments , this Phase III ...
View Page

4.  Study Posting (4519) Trial #98094, Non-Small Cell Lung Cancer, Taipei, Taiwan
...Study Posting (4519) Trial #98094, Non-Small Cell Lung Cancer, Taipei, Taiwan Trial Information A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer. Status: No longer recruiting Protocol Number: ML20322 Sponsor: Roche Taiwan Company Division: Pharmaceutical Official ...
View Page

5.  Study Posting (5258) Trial #145392, Non-Small Cell Lung Cancer, Taichung, Taiwan
...Study Posting (5258) Trial #145392, Non-Small Cell Lung Cancer, Taichung, Taiwan Trial Information MAGRIT is a Phase III clinical study which evaluates the ...
...potential new immunotherapy (also called a therapeutic vaccine) in the treatment of Non-Small Cell Lung Cancer (NSCLC). Objective: Because of the needs for alternative lung cancer treatments , this Phase III ...
View Page

6.  Study Posting (5258) Trial #145391, Non-Small Cell Lung Cancer, Zuerich, Switzerland
...Study Posting (5258) Trial #145391, Non-Small Cell Lung Cancer, Zuerich, Switzerland Trial Information MAGRIT is a Phase III clinical study which evaluates the ...
...potential new immunotherapy (also called a therapeutic vaccine) in the treatment of Non-Small Cell Lung Cancer (NSCLC). Objective: Because of the needs for alternative lung cancer treatments , this Phase III ...
View Page

7.  Study Posting (5258) Trial #145390, Non-Small Cell Lung Cancer, Thun, Switzerland
...Study Posting (5258) Trial #145390, Non-Small Cell Lung Cancer, Thun, Switzerland Trial Information MAGRIT is a Phase III clinical study which evaluates the ...
...potential new immunotherapy (also called a therapeutic vaccine) in the treatment of Non-Small Cell Lung Cancer (NSCLC). Objective: Because of the needs for alternative lung cancer treatments , this Phase III ...
View Page

8.  Study Posting (5258) Trial #145389, Non-Small Cell Lung Cancer, Bern, Switzerland
...Study Posting (5258) Trial #145389, Non-Small Cell Lung Cancer, Bern, Switzerland Trial Information MAGRIT is a Phase III clinical study which evaluates the ...
...potential new immunotherapy (also called a therapeutic vaccine) in the treatment of Non-Small Cell Lung Cancer (NSCLC). Objective: Because of the needs for alternative lung cancer treatments , this Phase III ...
View Page

9.  Study Posting (5258) Trial #150474, Non-Small Cell Lung Cancer, Bruderholz, Switerland
...Study Posting (5258) Trial #150474, Non-Small Cell Lung Cancer, Bruderholz, Switerland Trial Information MAGRIT is a Phase III clinical study which evaluates the ...
...potential new immunotherapy (also called a therapeutic vaccine) in the treatment of Non-Small Cell Lung Cancer (NSCLC). Objective: Because of the needs for alternative lung cancer treatments , this Phase III ...
View Page

10.  Study Posting (5258) Trial #145388, Non-Small Cell Lung Cancer, UPPSALA, Sweden
...Study Posting (5258) Trial #145388, Non-Small Cell Lung Cancer, UPPSALA, Sweden Trial Information MAGRIT is a Phase III clinical study which evaluates the ...
...potential new immunotherapy (also called a therapeutic vaccine) in the treatment of Non-Small Cell Lung Cancer (NSCLC). Objective: Because of the needs for alternative lung cancer treatments , this Phase III ...
View Page

11.  Study Posting (5258) Trial #145387, Non-Small Cell Lung Cancer, STOCKHOLM, Sweden
...Study Posting (5258) Trial #145387, Non-Small Cell Lung Cancer, STOCKHOLM, Sweden Trial Information MAGRIT is a Phase III clinical study which evaluates the ...
...potential new immunotherapy (also called a therapeutic vaccine) in the treatment of Non-Small Cell Lung Cancer (NSCLC). Objective: Because of the needs for alternative lung cancer treatments , this Phase III ...
View Page

12.  Study Posting (5258) Trial #145386, Non-Small Cell Lung Cancer, LUND, Sweden
...Study Posting (5258) Trial #145386, Non-Small Cell Lung Cancer, LUND, Sweden Trial Information MAGRIT is a Phase III clinical study which evaluates the ...
...potential new immunotherapy (also called a therapeutic vaccine) in the treatment of Non-Small Cell Lung Cancer (NSCLC). Objective: Because of the needs for alternative lung cancer treatments , this Phase III ...
View Page

13.  Study Posting (5258) Trial #145385, Non-Small Cell Lung Cancer, Valencia, Spain
...Study Posting (5258) Trial #145385, Non-Small Cell Lung Cancer, Valencia, Spain Trial Information MAGRIT is a Phase III clinical study which evaluates the ...
...potential new immunotherapy (also called a therapeutic vaccine) in the treatment of Non-Small Cell Lung Cancer (NSCLC). Objective: Because of the needs for alternative lung cancer treatments , this Phase III ...
View Page

14.  Study Posting (5258) Trial #145384, Non-Small Cell Lung Cancer, Sevilla, Spain
...Study Posting (5258) Trial #145384, Non-Small Cell Lung Cancer, Sevilla, Spain Trial Information MAGRIT is a Phase III clinical study which evaluates the ...
...potential new immunotherapy (also called a therapeutic vaccine) in the treatment of Non-Small Cell Lung Cancer (NSCLC). Objective: Because of the needs for alternative lung cancer treatments , this Phase III ...
View Page

15.  Study Posting (5258) Trial #145383, Non-Small Cell Lung Cancer, Santander, Spain
...Study Posting (5258) Trial #145383, Non-Small Cell Lung Cancer, Santander, Spain Trial Information MAGRIT is a Phase III clinical study which evaluates the ...
...potential new immunotherapy (also called a therapeutic vaccine) in the treatment of Non-Small Cell Lung Cancer (NSCLC). Objective: Because of the needs for alternative lung cancer treatments , this Phase III ...
View Page

16.  Study Posting (5258) Trial #145382, Non-Small Cell Lung Cancer, Oviedo, Spain
...Study Posting (5258) Trial #145382, Non-Small Cell Lung Cancer, Oviedo, Spain Trial Information MAGRIT is a Phase III clinical study which evaluates the ...
...potential new immunotherapy (also called a therapeutic vaccine) in the treatment of Non-Small Cell Lung Cancer (NSCLC). Objective: Because of the needs for alternative lung cancer treatments , this Phase III ...
View Page

17.  Study Posting (5258) Trial #145381, Non-Small Cell Lung Cancer, Madrid, Spain
...Study Posting (5258) Trial #145381, Non-Small Cell Lung Cancer, Madrid, Spain Trial Information MAGRIT is a Phase III clinical study which evaluates the ...
...potential new immunotherapy (also called a therapeutic vaccine) in the treatment of Non-Small Cell Lung Cancer (NSCLC). Objective: Because of the needs for alternative lung cancer treatments , this Phase III ...
View Page

18.  Study Posting (5258) Trial #145380, Non-Small Cell Lung Cancer, Lerida, Spain
...Study Posting (5258) Trial #145380, Non-Small Cell Lung Cancer, Lerida, Spain Trial Information MAGRIT is a Phase III clinical study which evaluates the ...
...potential new immunotherapy (also called a therapeutic vaccine) in the treatment of Non-Small Cell Lung Cancer (NSCLC). Objective: Because of the needs for alternative lung cancer treatments , this Phase III ...
View Page

19.  Study Posting (5258) Trial #145379, Non-Small Cell Lung Cancer, Barcelona, Spain
...Study Posting (5258) Trial #145379, Non-Small Cell Lung Cancer, Barcelona, Spain Trial Information MAGRIT is a Phase III clinical study which evaluates the ...
...potential new immunotherapy (also called a therapeutic vaccine) in the treatment of Non-Small Cell Lung Cancer (NSCLC). Objective: Because of the needs for alternative lung cancer treatments , this Phase III ...
View Page

20.  Study Posting (5258) Trial #145378, Non-Small Cell Lung Cancer, Singapore, Singapore
...Study Posting (5258) Trial #145378, Non-Small Cell Lung Cancer, Singapore, Singapore Trial Information MAGRIT is a Phase III clinical study which evaluates the ...
...potential new immunotherapy (also called a therapeutic vaccine) in the treatment of Non-Small Cell Lung Cancer (NSCLC). Objective: Because of the needs for alternative lung cancer treatments , this Phase III ...
View Page